GB201607778D0 - Drug delivery device - Google Patents

Drug delivery device

Info

Publication number
GB201607778D0
GB201607778D0 GBGB1607778.6A GB201607778A GB201607778D0 GB 201607778 D0 GB201607778 D0 GB 201607778D0 GB 201607778 A GB201607778 A GB 201607778A GB 201607778 D0 GB201607778 D0 GB 201607778D0
Authority
GB
United Kingdom
Prior art keywords
delivery device
drug delivery
drug
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1607778.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University of Belfast
Original Assignee
Queens University of Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens University of Belfast filed Critical Queens University of Belfast
Priority to GBGB1607778.6A priority Critical patent/GB201607778D0/en
Publication of GB201607778D0 publication Critical patent/GB201607778D0/en
Priority to PCT/GB2017/051247 priority patent/WO2017191457A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
GBGB1607778.6A 2016-05-04 2016-05-04 Drug delivery device Ceased GB201607778D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1607778.6A GB201607778D0 (en) 2016-05-04 2016-05-04 Drug delivery device
PCT/GB2017/051247 WO2017191457A1 (en) 2016-05-04 2017-05-04 Drug delivery device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1607778.6A GB201607778D0 (en) 2016-05-04 2016-05-04 Drug delivery device

Publications (1)

Publication Number Publication Date
GB201607778D0 true GB201607778D0 (en) 2016-06-15

Family

ID=56234362

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1607778.6A Ceased GB201607778D0 (en) 2016-05-04 2016-05-04 Drug delivery device

Country Status (2)

Country Link
GB (1) GB201607778D0 (en)
WO (1) WO2017191457A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111278503B (en) * 2017-09-12 2023-12-05 Lts勒曼治疗系统股份公司 Iontophoresis microneedle device
CN109367963B (en) * 2018-11-30 2020-11-10 北京小米移动软件有限公司 Packaging box, damage detection method and device, detection equipment and storage medium
CN116870348A (en) * 2022-05-25 2023-10-13 迈德科莱(杭州)生物技术有限公司 Super-swelling microneedle patch and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5876468B2 (en) * 2011-02-25 2016-03-02 久光製薬株式会社 Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing the same

Also Published As

Publication number Publication date
WO2017191457A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
HK1247875A1 (en) Drug delivery device
HK1248626A1 (en) Drug delivery device
IL249777A0 (en) Drug delivery device
HK1247878A1 (en) Drug delivery device
EP3265064A4 (en) Drug delivery device
HK1246707A1 (en) Drug delivery device
PL3171921T3 (en) Drug delivery device
IL250813A0 (en) Drug delivery device
GB201612516D0 (en) Medicament delivery device
ZAA201800376S (en) Drug delivery devices
HK1244733A1 (en) Drug delivery device
GB201506788D0 (en) Medicament delivery device
EP3720522C0 (en) Drug delivery device
HK1258971A1 (en) Medical delivery device
PT3622986T (en) Medicament delivery device
GB201712184D0 (en) Medicament delivery device
HUE052701T2 (en) Drug delivery devices
IL249789A0 (en) Drug delivery device
GB201619562D0 (en) Medicament delivery device
GB2537639B (en) Medicament delivery device
ZA201800586B (en) A drug delivery device
LT3449892T (en) Drug dispensing device
GB201619556D0 (en) Medicament delivery device
GB201607778D0 (en) Drug delivery device
GB2529249B (en) Endoluminal drug delivery device

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)